Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rick barrows who wrote (515)	3/26/1999 12:41:00 AM
From: tuck	Read Replies (1) of 2515

Rick, I said a couple of months tops, because the renal cell carcinoma trials may yield reportable results then as you say. I am assuming that IMCL won't have anything new to say at AACR. Thus not much news, a situation that tends to see development stage biotech stocks drift downward, in my experience. Volume seems to be slowing down again as it tests 14. I'm not technician enough to say anything about that. Hey, we're posting at the same time: just read your #519. Good DD! Did the abstracts mention what kinds of cancer? It's hard to imagine animal data (albeit with human tissue xenografted) on this drug would add substantially to the hype already surrounding it, unless it's for indications not previously mentioned that also have big markets. Thoughts, troops? Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next